RESUMO
In recent years, microRNAs (miRNAs) have garnered increasing attention for their potential implications in cancer pathogenesis, functioning either as oncogenes or tumor suppressors. Notably, angiosarcoma, along with various other cardiovascular tumors such as lipomas, rhabdomyomas, hemangiomas, and myxomas, has shown variations in the expression of specific miRNA subtypes. A substantial body of evidence underscores the pivotal involvement of miRNAs in the genesis of angiosarcoma and certain cardiovascular tumors. This review aims to delve into the current literature on miRNAs and their prospective applications in cardiovascular malignancies, with a specific focus on angiosarcoma. It comprehensively covers diagnostic methods, prognostic evaluations, and potential treatments while providing a recapitulation of angiosarcoma's risk factors and molecular pathogenesis, with an emphasis on the role of miRNAs. These insights can serve as the groundwork for designing randomized control trials, ultimately facilitating the translation of these findings into clinical applications. Moving forward, it is imperative for studies to thoroughly scrutinize the advantages and disadvantages of miRNAs compared to current diagnostic and prognostic approaches in angiosarcoma and other cardiovascular tumors. Closing these knowledge gaps will be crucial for harnessing the full potential of miRNAs in the realm of angiosarcoma and cardiovascular tumor research.
RESUMO
Urtica dioica or stinging nettle is traditionally used as an herbal medicine in Western Asia. The current study represents the investigation of antimicrobial activity of U. dioica from nine crude extracts that were prepared using different organic solvents, obtained from two extraction methods: the Soxhlet extractor (Method I), which included the use of four solvents with ethyl acetate and hexane, or the sequential partitions (Method II) with a five solvent system (butanol). The antibacterial and antifungal activities of crude extracts were tested against 28 bacteria, three yeast strains and seven fungal isolates by the disc diffusion and broth dilution methods. Amoxicillin was used as positive control for bacteria strains, vancomycin for Streptococcus sp., miconazole nitrate (30µg/mL) as positive control for fungi and yeast, and pure methanol (v/v) as negative control. The disc diffusion assay was used to determine the sensitivity of the samples, whilst the broth dilution method was used for the determination of the minimal inhibition concentration (MIC). The ethyl acetate and hexane extract from extraction method I (EA I and HE I) exhibited highest inhibition against some pathogenic bacteria such as Bacillus cereus, MRSA and Vibrio parahaemolyticus. A selection of extracts that showed some activity was further tested for the MIC and minimal bactericidal concentrations (MBC). MIC values of Bacillus subtilis and Methicillin-resistant Staphylococcus aureus (MRSA) using butanol extract of extraction method II (BE II) were 8.33 and 16.33mg/mL, respectively; while the MIC value using ethyl acetate extract of extraction method II (EAE II) for Vibrio parahaemolyticus was 0.13mg/mL. Our study showed that 47.06% of extracts inhibited Gram-negative (8 out of 17), and 63.63% of extracts also inhibited Gram-positive bacteria (7 out of 11); besides, statistically the frequency of antimicrobial activity was 13.45% (35 out of 342) which in this among 21.71% belongs to antimicrobial activity extracts from extraction method I (33 out of 152 of crude extracts) and 6.82% from extraction method II (13 out of 190 of crude extracts). However, crude extracts from method I exhibited better antimicrobial activity against the Gram-positive bacteria than the Gram-negative bacteria. The positive results on medicinal plants screening for antibacterial activity constitutes primary information for further phytochemical and pharmacological studies. Therefore, the extracts could be suitable as antimicrobial agents in pharmaceutical and food industry.
Urtica dioica u ortiga se utiliza tradicionalmente como medicina herbaria en el oeste de Asia. En esta investigación se estudia la actividad antimicrobiana de nueve extractos crudos de U. dioica, los cuales fueron preparados utilizando diferentes disolventes orgánicos y obtenidos a partir de dos métodos de extracción: el extractor Soxhlet (Método I), que incluía el uso de cuatro disolventes con acetato de etilo y hexano, y las particiones secuenciales (Método II) con un sistema de cinco disolventes (butanol). Las actividades antibacterianas y antifúngicas de extractos crudos fueron ensayados contra 28 bacterias, tres cepas de levadura y siete cepas fúngicas por la difusión en disco y el método de dilución en caldo. La amoxicilina se utilizó como control positivo para cepas de bacterias, vancomicina para Streptococcus sp., nitrato de miconazol (30μg/mL) como control positivo para los hongos y levaduras, y el metanol puro (v / v) como control negativo. El ensayo de difusión en disco se utilizó para determinar la sensibilidad de las muestras, mientras que el método de dilución en caldo se utilizó para la determinación de la concentración de inhibición mínima (CIM). El acetato de etilo y el extracto de hexano del método de extracción I (AE I y EH I) mostraron mayor inhibición contra algunas bacterias patógenas tales como Bacillus cereus, MRSA y Vibrio parahaemolyticus. Una selección de extractos que mostraron algún tipo de actividad se probó para el CIM y las concentraciones mínimas bactericidas (CMB). Los valores de CIM de Bacillus subtilis y de Staphylococcus aureus resistentes a la meticilina (MRSA) usando extracto de butanol mediante el método de extracción II (EB II) fueron: 8.33 y 16.33mg/ mL, respectivamente; mientras que el valor de MIC con el uso del extracto de acetato de etilo por el Método de extracción II (EAE II) para Vibrio parahaemolyticus fue 0.13mg/mL. Nuestro estudio mostró que el 47.06% de los extractos inhibieron bacterias Gram-negativas (8 de 17), y el 63,63% de los extractos también inhibieron bacterias Gram-positivas (7 de 11), además que estadísticamente la frecuencia de la actividad antimicrobiana fue de 13.45% (35 de 342), que de este porcentaje un 21.71% pertenece alos extractos de actividad antimicrobiana con el método de extracción I (33 de 152 de los extractos crudos) y un 6.82% del método de extracción II (13 de 190 de los extractos crudos). Sin embargo, los extractos crudos del método I exhibieron una mejor actividad antimicrobiana contra las bacterias Gram-positivas que las Gram-negativas. Los resultados positivos en la detección de plantas medicinales para la actividad antibacteriana constituye información primaria para la realización de nuevos estudios fitoquímicos y farmacológicos. Por lo tanto, los extractos podrían ser adecuados como agentes antimicrobianos en la industria farmacéutica y de alimentos.